Affiliation:
1. Department of Clinical Laboratory, Peking University People’s Hospital, Beijing, China
Abstract
Multidrug-resistant
Acinetobacter baumannii
poses a huge challenge to clinical treatment, and tigecycline is considered a last-line drug for the treatment of multidrug-resistant
A. baumannii
. However, the mechanism of tigecycline resistance
in vivo
has not been elucidated.
Funder
National Natural Science Foundation of China
Peking University People's Hospital
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Cell Biology,Microbiology (medical),Genetics,General Immunology and Microbiology,Ecology,Physiology
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献